Benzinga - Fri, 09 Apr 2021 12:44:35 -0400
Benzinga - Thu, 08 Apr 2021 13:08:40 -0400
Benzinga - Thu, 08 Apr 2021 08:01:58 -0400
Benzinga - Wed, 07 Apr 2021 03:11:08 -0400
Benzinga - Tue, 06 Apr 2021 12:04:38 -0400
Benzinga - Tue, 06 Apr 2021 11:48:30 -0400
Benzinga - Tue, 06 Apr 2021 05:13:04 -0400
Benzinga - Mon, 05 Apr 2021 10:19:05 -0400
Benzinga - Wed, 17 Mar 2021 10:40:48 -0400
Benzinga - Wed, 17 Mar 2021 09:39:00 -0400
Benzinga - Wed, 17 Mar 2021 08:09:59 -0400
Benzinga - Wed, 17 Mar 2021 08:03:00 -0400
Benzinga - Wed, 17 Mar 2021 07:25:09 -0400
Benzinga - Wed, 10 Mar 2021 08:19:45 -0400
Benzinga - Wed, 10 Mar 2021 06:19:51 -0400
load more
Sector: Health Care.Industry: Biotechnology
GT Biopharma Inc is an immuno-oncology company operating in the United States. It is engaged in discovering, developing and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its key drug candidates are OXS-2175, targeting the treatment of triple-negative breast cancer; OXS-4235, targets the treatment of multiple myeloma and associated osteolytic lesions; and OXS-1550, targets cancer cells expressing the CD19 receptor and CD22 receptor. Its TriKE and TetraKE platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
GTBPGT Biopharma0%223.1M

GT Biopharma Company Questions & Answers

Q

How do I buy GT Biopharma (GTBP) stock?

A

You can purchase shares of GT Biopharma (NASDAQ: GTBP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are GT Biopharma's (GTBP) main competitors?

A

Other companies in GT Biopharma’s space includes: Voyager Therapeutics (NASDAQ:VYGR), DiaMedica Therapeutics (NASDAQ:DMAC) and Calithera Biosciences (NASDAQ:CALA).

Q

What is the target price for GT Biopharma?

A

The latest price target for GT Biopharma (NASDAQ: GTBP) was reported by Roth Capital on 2021-03-17. The analyst firm set a price target for 25.00 expecting GTBP to rise to within 12 months (a possible 139.46% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is GT Biopharma (GTBP) stock ?

A

The stock price for GT Biopharma (NASDAQ: GTBP) is $10.44 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next GT Biopharma (GTBP) dividend?

A

There are no upcoming dividends for GT Biopharma.

Q

When is GT Biopharma (NASDAQ:GTBP) reporting earnings?

A

There are no earnings for GT Biopharma

Q

When is the upcoming split for GTBP?

A

There is no upcoming split for GT Biopharma.